AstraZeneca Inks R&D Deal With Ramaswamy's Roivant for Hush-Hush Indication Post author:Sam Post published:October 18, 2017 Post category:BioPharma Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Astra. Source: BioSpace You Might Also Like Crippled Bay Area Pharma Threshold Rockets on Reverse Merger Deal With Molecular Templates March 16, 2017 Hundreds of Jobs to Go as GlaxoSmithKline Shutters Manufacturing Site July 19, 2017 OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017
Crippled Bay Area Pharma Threshold Rockets on Reverse Merger Deal With Molecular Templates March 16, 2017
OMEICOS Therapeutics Secures Extension Of Series B Financing Round To Expand Its Technology Into Ophthalmology October 4, 2017
